Technical Analysis for ALRN - Aileron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.2 -18.92% -0.28
ALRN closed up 0.68 percent on Thursday, January 17, 2019, on 1.74 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ALRN trend table...

Date Alert Name Type % Chg
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -18.92%
Jan 17 Pocket Pivot Bullish Swing Setup -18.92%
Jan 17 Calm After Storm Range Contraction -18.92%
Jan 17 Inside Day Range Contraction -18.92%
Jan 17 Wide Bands Range Expansion -18.92%
Jan 17 Above Upper BB Strength -18.92%
Jan 17 Up 3 Days in a Row Strength -18.92%
Jan 17 Up 4 Days in a Row Strength -18.92%
Jan 17 Upper Bollinger Band Touch Strength -18.92%
Jan 16 50 DMA Resistance Bearish -18.37%

Older signals for ALRN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and metabolic diseases and inflammation. The Company is advancing its lead oncology program to deliver efficacy and safety in a spectrum of solid and hematological malignancies. Its lead product candidate, ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers. The Company is conducting an ongoing Phase I clinical trial of ALRN-6924 in adult patients with solid tumors or lymphomas expressing non-mutated or wild-type p53 that are refractory to or intolerant of standard therapy. ALRN-6924 may reactivate p53-mediated cell death by targeting both of the natural p53 suppressor proteins, Mouse double minute 2 homolog (MDM2) and MDMX.
Is ALRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.88
52 Week Low 0.52
Average Volume 160,213
200-Day Moving Average 3.5014
50-Day Moving Average 1.5663
20-Day Moving Average 1.0008
10-Day Moving Average 1.176
Average True Range 0.224
ADX 29.54
+DI 33.4471
-DI 17.8978
Chandelier Exit (Long, 3 ATRs ) 1.168
Chandelier Exit (Short, 3 ATRs ) 1.192
Upper Bollinger Band 1.456
Lower Bollinger Band 0.5456
Percent B (%b) 1.03
BandWidth 90.967226
MACD Line -0.0618
MACD Signal Line -0.1571
MACD Histogram 0.0952
Fundamentals Value
Market Cap 21.78 Million
Num Shares 14.7 Million
EPS -41.73
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.83
Resistance 3 (R3) 1.79 1.63 1.77
Resistance 2 (R2) 1.63 1.55 1.65 1.75
Resistance 1 (R1) 1.56 1.49 1.60 1.60 1.73
Pivot Point 1.40 1.40 1.42 1.42 1.40
Support 1 (S1) 1.33 1.32 1.37 1.37 1.23
Support 2 (S2) 1.17 1.26 1.19 1.21
Support 3 (S3) 1.10 1.17 1.19
Support 4 (S4) 1.14